ArticleColorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland2025
The DIVIPACT cohort profile: Evaluating the impact of colonic diverticulosis on daily life.
Article in Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The DIVIPACT cohort profile: Evaluating the impact of colonic diverticulosis on daily life.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
aimColonic diverticulosis is asymptomatic in most subjects but can impact daily life. The DIVIPACT study comprehensively explores the impact of diverticulosis on daily life. The aim of this publication is to introduce the DIVIPACT cohort, present self-reported data from a cross-sectional survey and outline the potential for further research.
methodThe DIVIPACT cohort comprises subjects diagnosed with diverticulosis (K572-9) in the Central Denmark Region (five hospitals, ~1.3 million residents) between 2010 and 2022 who responded to an online questionnaire survey conducted in 2023 assessing health factors and quality of life (QoL). Self-reported data were linked to Danish health registries for consenting responders. Responders were categorized according to previous hospital management (inpatient, outpatient or diverticulosis) and characterized based on self-reported health factors.
resultsOf the 20 961 responders (74% response rate), 19 244 (92%) consented to data linkage. Among these, 4184 (22%) were inpatients, 8666 (45%) were outpatients and 6394 (33%) had diverticulosis only. Overall, 1596 (10%) reported restrictions on activity due to diverticulosis in the past 4 weeks. Bowel function affected QoL in 66% of inpatients, 54% of outpatients and 44% of diverticulosis-only individuals.
conclusionThe DIVIPACT cohort provides one of the most extensive datasets available for evaluating the impact of colonic diverticulosis on daily life, addressing important knowledge gaps and providing a foundation for patient-centred management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.